151 related articles for article (PubMed ID: 35831019)
1. PPP2R2D Suppresses Effector T Cell Exhaustion and Regulatory T Cell Expansion and Inhibits Tumor Growth in Melanoma.
Pan W; Scherlinger M; Yoshida N; Tsokos MG; Tsokos GC
J Immunol; 2022 Aug; 209(3):621-628. PubMed ID: 35831019
[TBL] [Abstract][Full Text] [Related]
2. PPP2R2D suppresses IL-2 production and Treg function.
Pan W; Sharabi A; Ferretti A; Zhang Y; Burbano C; Yoshida N; Tsokos MG; Tsokos GC
JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32897879
[TBL] [Abstract][Full Text] [Related]
3. SOCS1 Is a Key Molecule That Prevents Regulatory T Cell Plasticity under Inflammatory Conditions.
Takahashi R; Nakatsukasa H; Shiozawa S; Yoshimura A
J Immunol; 2017 Jul; 199(1):149-158. PubMed ID: 28550203
[TBL] [Abstract][Full Text] [Related]
4. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
[TBL] [Abstract][Full Text] [Related]
5. Co-expression of LAG3 and TIM3 identifies a potent Treg population that suppresses macrophage functions in colorectal cancer patients.
Ma Q; Liu J; Wu G; Teng M; Wang S; Cui M; Li Y
Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):1002-1009. PubMed ID: 29905955
[TBL] [Abstract][Full Text] [Related]
6. Remodeling of the tumor microenvironment via disrupting Blimp1
Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated Tregs obstruct antitumor immunity by promoting T cell dysfunction and restricting clonal diversity in tumor-infiltrating CD8+ T cells.
Noyes D; Bag A; Oseni S; Semidey-Hurtado J; Cen L; Sarnaik AA; Sondak VK; Adeegbe D
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35618289
[TBL] [Abstract][Full Text] [Related]
8. An exhaustion-like phenotype constrains the activity of CD4+ T cells specific for a self and melanoma antigen.
Rausch MP; Hastings KT
PLoS One; 2015; 10(4):e0123332. PubMed ID: 25875653
[TBL] [Abstract][Full Text] [Related]
9. Type 17 immunity promotes the exhaustion of CD8
Kim BS; Kuen DS; Koh CH; Kim HD; Chang SH; Kim S; Jeon YK; Park YJ; Choi G; Kim J; Kang KW; Kim HY; Kang SJ; Hwang S; Shin EC; Kang CY; Dong C; Chung Y
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34083422
[TBL] [Abstract][Full Text] [Related]
10. PPP2R2D, a regulatory subunit of protein phosphatase 2A, promotes gastric cancer growth and metastasis via mechanistic target of rapamycin activation.
Yu S; Li L; Wu Q; Dou N; Li Y; Gao Y
Int J Oncol; 2018 Jun; 52(6):2011-2020. PubMed ID: 29568966
[TBL] [Abstract][Full Text] [Related]
11. JunB plays a crucial role in development of regulatory T cells by promoting IL-2 signaling.
Katagiri T; Yamazaki S; Fukui Y; Aoki K; Yagita H; Nishina T; Mikami T; Katagiri S; Shiraishi A; Kimura S; Tateda K; Sumimoto H; Endo S; Kameda H; Nakano H
Mucosal Immunol; 2019 Sep; 12(5):1104-1117. PubMed ID: 31285535
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-35 Limits Anti-Tumor Immunity.
Turnis ME; Sawant DV; Szymczak-Workman AL; Andrews LP; Delgoffe GM; Yano H; Beres AJ; Vogel P; Workman CJ; Vignali DA
Immunity; 2016 Feb; 44(2):316-29. PubMed ID: 26872697
[TBL] [Abstract][Full Text] [Related]
13. Deletion of PD-1 destabilizes the lineage identity and metabolic fitness of tumor-infiltrating regulatory T cells.
Kim MJ; Kim K; Park HJ; Kim GR; Hong KH; Oh JH; Son J; Park DJ; Kim D; Choi JM; Lee I; Ha SJ
Nat Immunol; 2023 Jan; 24(1):148-161. PubMed ID: 36577929
[TBL] [Abstract][Full Text] [Related]
14. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
15. Loss of TET2 and TET3 in regulatory T cells unleashes effector function.
Yue X; Lio CJ; Samaniego-Castruita D; Li X; Rao A
Nat Commun; 2019 May; 10(1):2011. PubMed ID: 31043609
[TBL] [Abstract][Full Text] [Related]
16. PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells.
Wang W; Lau R; Yu D; Zhu W; Korman A; Weber J
Int Immunol; 2009 Sep; 21(9):1065-77. PubMed ID: 19651643
[TBL] [Abstract][Full Text] [Related]
17. Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion.
Alvarez M; Simonetta F; Baker J; Morrison AR; Wenokur AS; Pierini A; Berraondo P; Negrin RS
Front Immunol; 2020; 11():7. PubMed ID: 32117218
[TBL] [Abstract][Full Text] [Related]
18. Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.
Knol AC; Lemaître F; Pandolfino MC; Volteau C; Quéreux G; Saiagh S; Khammari A; Viguier M; Dréno B
Exp Dermatol; 2008 May; 17(5):436-45. PubMed ID: 18312383
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
Singh AK; Horvath KA; Mohiuddin MM
Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
[TBL] [Abstract][Full Text] [Related]
20. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer.
Twyman-Saint Victor C; Rech AJ; Maity A; Rengan R; Pauken KE; Stelekati E; Benci JL; Xu B; Dada H; Odorizzi PM; Herati RS; Mansfield KD; Patsch D; Amaravadi RK; Schuchter LM; Ishwaran H; Mick R; Pryma DA; Xu X; Feldman MD; Gangadhar TC; Hahn SM; Wherry EJ; Vonderheide RH; Minn AJ
Nature; 2015 Apr; 520(7547):373-7. PubMed ID: 25754329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]